|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 16 November 2004
doi: 10.1242/jcs.01548
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
1 Cardiovascular Research Institute, University of California, San Francisco, CA 94143, USA
2 Department of Pediatrics, University of California, San Francisco, CA 94143, USA
3 Cancer Center, University of California, San Francisco, CA 94143, USA
4 Life Sciences Division, Genome Sciences, Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
* Author for correspondence (e-mail: hsbernstein{at}pedcard.ucsf.edu)
Accepted 21 September 2004
Extracellular signaling pathways regulating myoblast differentiation and cell-cycle withdrawal are not completely understood. Stem cell antigen-1 (Sca-1/Ly-6A/E) is a glycosylphosphatidylinositol-anchored membrane protein known for its role in T-cell activation, and recently described as a marker for regeneration-competent myoblasts. We previously determined that expression of Sca-1/Ly-6A is transiently upregulated during myocyte cell-cycle withdrawal; however, a specific function for Sca-1 in myogenesis has not been described. Here, we show that Sca-1 expression on the surface of a subpopulation of differentiating C2C12 myoblasts is maximal at the time of cell-cycle withdrawal, and that blocking Sca-1 with monoclonal antibodies or downregulating Sca-1 expression by antisense both promotes proliferation and inhibits myotube formation. Downregulating Sca-1 expression derepresses Fyn at the time of myoblast cell-cycle withdrawal, and dominant-negative and constitutively active Fyn mutants rescue and recapitulate the Sca-1 antisense phenotype, respectively. This suggests a Fyn-mediated mechanism for Sca-1 action. Thus, we demonstrate an unprecedented role for Sca-1 in early myogenesis in C2C12 cells, and propose a novel pathway from the myoblast cell surface to intracellular signaling networks controlling proliferation versus differentiation in mammalian muscle. These findings suggest that, beyond its role as a marker for muscle progenitors, Sca-1 may be an important therapeutic target for promoting muscle regeneration.
Key words: Sca-1, Myoblast fusion, Cell-cycle withdrawal, Ly-6, GPI-anchored proteins, Muscle regeneration
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
M. Hidestrand, S. Richards-Malcolm, C. M. Gurley, G. Nolen, B. Grimes, A. Waterstrat, G. V. Zant, and C. A. Peterson Sca-1-Expressing Nonmyogenic Cells Contribute to Fibrosis in Aged Skeletal Muscle J Gerontol A Biol Sci Med Sci, June 1, 2008; 63(6): 566 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Spooncer, N. Brouard, S. K. Nilsson, B. Williams, M. C. Liu, R. D. Unwin, D. Blinco, E. Jaworska, P. J. Simmons, and A. D. Whetton Developmental Fate Determination and Marker Discovery in Hematopoietic Stem Cell Biology Using Proteomic Fingerprinting Mol. Cell. Proteomics, March 1, 2008; 7(3): 573 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, G. Wu, and Y. Wan The dual effects of Cdh1/APC in myogenesis FASEB J, November 1, 2007; 21(13): 3606 - 3617. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Asakura, H. Hirai, B. Kablar, S. Morita, J. Ishibashi, B. A. Piras, A. J. Christ, M. Verma, K. A. Vineretsky, and M. A. Rudnicki Increased survival of muscle stem cells lacking the MyoD gene after transplantation into regenerating skeletal muscle PNAS, October 16, 2007; 104(42): 16552 - 16557. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dekel, L. Zangi, E. Shezen, S. Reich-Zeliger, S. Eventov-Friedman, H. Katchman, J. Jacob-Hirsch, N. Amariglio, G. Rechavi, R. Margalit, et al. Isolation and Characterization of Nontubular Sca-1+Lin- Multipotent Stem/Progenitor Cells from Adult Mouse Kidney J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3300 - 3314. [Abstract] [Full Text] [PDF] |
||||